Medical Devices

University Medical School in Munich, Germany expands capacity for cancer treatment

Published in Cancer Weekly, January 10th, 2006

BSD Medical Corp. (BSM) announced that a third BSD-2000 cancer treatment system has been purchased and installed at the University Medical School in Munich, Germany to support the the school's groundbreaking work in advanced new treatment of rectal and pancreatic cancer.

The medical school has already conducted over 7,000 cancer treatments on its two existing BSD-2000s.

Improved treatment for these two cancers is a high priority, as rectal cancer is the second leading cause of death from cancer, with pancreatic cancer following as fourth. Expanding the use of the BSD-2000 for treatment of these cancers is expected to further demonstrate and broaden...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2006-01-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry